Expression of α-taxilin in hepatocellular carcinoma correlates with growth activity and malignant potential of the tumor

The membrane traffic system has been recognized to be involved in carcinogenesis and tumor progression in several types of tumors a-taxilin is a newly identified membrane traffic-related molecule, and its up-regulation has been reported in embryonic and malignant tissues of neural origin In the present study, we analyzed the expression of a-taxilin in relation to clinicopathological features of hepatocellular carcinomas (HCC) and proliferative activity of the tumor determined by proliferating cell nuclear antigen labeling index (PCNA-LI) Twenty-nine surgically resected nodules of HCC (8 well-, 11 moderately-, and 10 poorly-differentiated) were studied Fifteen cases showed 'strong staining', while 14 cases showed 'weak staining' for a-taxilin A significantly higher expression of a-taxilin was observed in less-differentiated (p=0 005), and more invasive (p=0 016) HCCs The 'strong staining' group showed significantly higher PCNA-LI than the 'weak staining' group (the medians of PCNA-LI were 59 4% vs 14 4%, p<0 0001) We also evaluated the expression of a-taxilin in hepatoma cell lines (PLC/PRF/5 Hep 02 and HuH-6) in association with cell proliferation The expression levels of a-taxilin protein were correlated with their growth rates In conclusion the expression of the alpha-taxilm protein was related with an increased proliferative activity and a less-differentiated histological grade of HCC a-taxilin may be involved in cell proliferation of HCC, and its expression can be a marker of malignant potential of HCC